Leverage Robust LNP Analytical Methods to Generate Reproducible Data, Ensure Product Consistency & Accelerate Confident Regulatory Submissions to Support Genetic Medicine Approvals
With brand-new acquisitions announced between AbbVie and Capstan Therapeutics as well as Eli Lilly & Co and Verve Therapeutics, celebrating the huge attraction of leveraging LNPs for cell and gene therapies. There’s never been a better time for you and your team to join the only industry-led forum turbocharging LNP characterization to advance these drug products towards approval.
The 3rd LNP Characterization & Analytical Development Summit provides unrivalled, in-depth technical insights into how to overcome critical challenges in assessing targeted LNP surface functionalization, evaluating encapsulation efficiency for multivalent formulations, and aligning analytical results with process performance to build more robust regulatory submissions.
Join experts from Pfizer, Novo Nordisk, Prime Medicine, Tessera Therapeutics, GSK, Sanofi, Verve Therapeutics and more as we explore the cutting edge of LNP characterization and analytics. Don’t miss this opportunity to collaborate with the brightest minds shaping the future of LNP drug development.
I have attended every year’s LNP Characterization & Analytical Development Summit since its inauguration and learned from my industry and academic peers every year. It is a great opportunity for people working in this field to meet and share insights with each other, and I look forward to attending the summit again this year
Zack Zhang, Director, Analytical Research & Development,
Beam Therapeutics
Our Industry-Leading Speakers:
What to Expect:
90+
Attendees from ​Large Pharma, Innovative Biotech & Academia
24+
Expert Speakers at the Forefront of LNP Analytical Development
16+
Data-Driven Sessions
8+
Hours of Dedicated Networking Sessions 
6+
Deep Dive Workshops & Interactive Discussion Sessions
∞
Opportunities for Networking & Knowledge Sharing
Explore the Agenda
Experience a jam-packed agenda featuring the latest analytical advancements for targeted and multivalent LNPs, along with exclusive insights into cutting-edge characterization strategies for evaluating LNP size, morphology, and biodistribution
Partner With Us
Position yourself alongside other leading analytical and assay solution providers to ensure your brand is at the heart of LNP deals and collaborations
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all a wide variety of analytical strategies for advancing LNP drug products, and make critical connections during our dedicated networking sessions
s